StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

Goldenwell Biotech's gross margin for the twelve months ending Jun 30, 2026 was 21.8%. For fiscal 2025 it was 21.8%, against 46.0% the year before. The highest annual figure on record is 52.7% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202521.8%−24.2
FY2024Dec 31, 202446.0%+9.8
FY2023Dec 31, 202336.3%−16.4
FY2022Dec 31, 202252.7%+0.2
FY2021Dec 31, 202152.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 202521.8%−28.2
Q2 FY2024Jun 30, 202450.4%+0.4
Q4 FY2023Dec 31, 202328.1%−24.6
Q3 FY2023Sep 30, 202348.7%−3.9
Q2 FY2023Jun 30, 202350.0%−2.6
Q1 FY2023Mar 31, 202350.0%−2.5
Q3 FY2022Sep 30, 202252.7%+0.2
Q2 FY2022Jun 30, 202252.5%+0.0
Q1 FY2022Mar 31, 202252.6%–
Q4 FY2021Dec 31, 202152.5%–
Q3 FY2021Sep 30, 202152.5%–
Q2 FY2021Jun 30, 202152.5%–

More Goldenwell Biotech figures

See a number that looks wrong?